Skip to main content
Top
Published in: Documenta Ophthalmologica 3/2017

01-12-2017 | Clinical Case Report

Electrophysiological features and multimodal imaging in ritonavir-related maculopathy

Authors: Céline Faure, Michel Paques, Isabelle Audo

Published in: Documenta Ophthalmologica | Issue 3/2017

Login to get access

Abstract

Purpose

The purpose of this study is to report a case of ritonavir-related retinal toxicity followed over a year. Electrophysiological features and multimodal imaging, including adaptive optics, are provided and discussed.

Methods

Electrophysiological recordings and multimodal imaging were performed and repeated over 1 year.

Results

Fundus examination revealed crystalline maculopathy in conjunction with pigment disruption. Spectral domain optical coherence tomography displayed thinning of the macula without cysts. Autofluorescence imaging revealed a mixed pattern of complete loss of the autofluorescence in the area of retinal pigment deposit and an increased transmission of the autofluorescence in the area of retinal thinning. Fluorescein angiography ruled out parafoveal telangiectasia. Indocyanine green angiography was not contributive. Increased spacing of the macular cone mosaic, crystal deposits and pigment migrations were seen with adaptive optics. Full-field electroretinogram was slightly reduced for both eyes, especially in the light-adapted responses, and mfERG confirmed bilateral maculopathy. Functional and structural abnormalities did not change with follow-up besides constant pigmentary changes monitored with adaptive optics.

Conclusion

Ritonavir-related retinal toxicity is a maculopathy with peculiar features including crystalline and pigment migration associated with central or temporofoveolar thinning and inconstant macular telangiectasia. Despite drug cessation, retinal remodelling continues to progress.
Appendix
Available only for authorised users
Literature
1.
go back to reference Roe RH, Jumper JM, Gualino V, Wender J, McDonald HR, Johnson RN, Fu AD, Cunningham ET Jr (2011) Retinal pigment epitheliopathy, macular telangiectasis, and intraretinal crystal deposits in HIV-positive patients receiving ritonavir. Retina 31:559–565CrossRefPubMed Roe RH, Jumper JM, Gualino V, Wender J, McDonald HR, Johnson RN, Fu AD, Cunningham ET Jr (2011) Retinal pigment epitheliopathy, macular telangiectasis, and intraretinal crystal deposits in HIV-positive patients receiving ritonavir. Retina 31:559–565CrossRefPubMed
2.
go back to reference Leiner S (2012) Re: retinal pigment epitheliopathy, macular telangiectasis, and intraretinal crystal deposits in HIV-positive patients receiving ritonavir. Retina 32(2):411CrossRefPubMed Leiner S (2012) Re: retinal pigment epitheliopathy, macular telangiectasis, and intraretinal crystal deposits in HIV-positive patients receiving ritonavir. Retina 32(2):411CrossRefPubMed
4.
go back to reference McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, Bach M (2015) ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol 130(1):1–12CrossRefPubMed McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, Bach M (2015) ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol 130(1):1–12CrossRefPubMed
5.
go back to reference Biancardi AL, Curi ALL (2016) Retinal toxicity related to long-term use of ritonavir. Retina 36:229–231CrossRefPubMed Biancardi AL, Curi ALL (2016) Retinal toxicity related to long-term use of ritonavir. Retina 36:229–231CrossRefPubMed
7.
go back to reference Gocho K, Sarda V, Falah S, Sahel JA, Sennlaub F, Benchaboune M, Ullern M, Paques M (2013) Adaptive optics imaging of geographic atrophy. Invest Ophthalmol Vis Sci 54:3673–3680CrossRefPubMed Gocho K, Sarda V, Falah S, Sahel JA, Sennlaub F, Benchaboune M, Ullern M, Paques M (2013) Adaptive optics imaging of geographic atrophy. Invest Ophthalmol Vis Sci 54:3673–3680CrossRefPubMed
8.
go back to reference Fawzi AA, Lee NG, Eliott D, Song J, Stewart JM (2009) Retinal findings in patients with Alport Syndrome: expanding the clinical spectrum. Br J Ophthalmol 93(12):1606–1611CrossRefPubMed Fawzi AA, Lee NG, Eliott D, Song J, Stewart JM (2009) Retinal findings in patients with Alport Syndrome: expanding the clinical spectrum. Br J Ophthalmol 93(12):1606–1611CrossRefPubMed
9.
go back to reference Vadlapatla RK, Vadlapudi AD, Pal D, Mukherji M, Mitra AK (2014) Ritonavir inhibits HIF-1α-mediated VEGF expression in retinal pigment epithelial cells in vitro. Eye (Lond) 28(1):93–101CrossRef Vadlapatla RK, Vadlapudi AD, Pal D, Mukherji M, Mitra AK (2014) Ritonavir inhibits HIF-1α-mediated VEGF expression in retinal pigment epithelial cells in vitro. Eye (Lond) 28(1):93–101CrossRef
Metadata
Title
Electrophysiological features and multimodal imaging in ritonavir-related maculopathy
Authors
Céline Faure
Michel Paques
Isabelle Audo
Publication date
01-12-2017
Publisher
Springer Berlin Heidelberg
Published in
Documenta Ophthalmologica / Issue 3/2017
Print ISSN: 0012-4486
Electronic ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-017-9612-z

Other articles of this Issue 3/2017

Documenta Ophthalmologica 3/2017 Go to the issue